Form 4 Tracker
David Malcom Rodman

Chief Medical Officer · 15 filings · Latest: Jun 15, 2026

Mineralys Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MLYS
David Malcom RodmanChief Medical OfficerJun 17, 2026
Sale
$25.004,584$114.6K57,095
MLYS
David Malcom RodmanChief Medical OfficerJun 17, 2026
Option Exercise
$14.364,584$65.8K61,679
MLYS
David Malcom RodmanChief Medical OfficerJun 15, 2026
Sale
$23.819,890$235.5K57,095
MLYS
David Malcom RodmanChief Medical OfficerJun 15, 2026
Option Exercise
$10.203,542$36.1K66,985
MLYS
Rodman David MalcomJun 17, 2026
Proposed Sale
$25.004,584$114.6K
MLYS
Rodman David MalcomJun 15, 2026
Proposed Sale
$23.819,890$235.5K
MLYS
David Malcom RodmanChief Medical OfficerJun 12, 2026
Sale
$23.936,349$151.9K63,443
MLYS
David Malcom RodmanChief Medical OfficerJun 12, 2026
Option Exercise
$1.086,349$6.9K69,792
MLYS
David Malcom RodmanChief Medical OfficerJun 10, 2026
Sale
$25.002,170$54.3K63,443
MLYS
David Malcom RodmanChief Medical OfficerJun 10, 2026
Option Exercise
$16.002,170$34.7K65,613
MLYS
Rodman David MalcomJun 12, 2026
Proposed Sale
$23.936,349$151.9K
MLYS
Rodman David MalcomJun 10, 2026
Proposed Sale
$25.002,170$54.3K
MLYS
David Malcom RodmanChief Medical OfficerMay 18, 2026
Sale
$27.55417$11.5K63,443
MLYS
David Malcom RodmanChief Medical OfficerMay 18, 2026
Option Exercise
$15.44417$6.4K63,860
MLYS
Rodman David MalcomMay 18, 2026
Proposed Sale
$27.55417$11.5K
MLYS
David Malcom RodmanChief Medical OfficerMay 13, 2026
Sale
$28.5814,056$401.8K63,443
MLYS
David Malcom RodmanChief Medical OfficerMay 13, 2026
Option Exercise
$12.397,707$95.5K77,499
MLYS
David Malcom RodmanChief Medical OfficerMay 12, 2026
Sale
$29.366,348$186.3K69,792
MLYS
David Malcom RodmanChief Medical OfficerMay 12, 2026
Option Exercise
$1.086,348$6.9K76,140
MLYS
David Malcom RodmanChief Medical OfficerMay 11, 2026
Sale
$29.712,171$64.5K69,792

Page 1 of 4

Next →